Page last updated: 2024-08-16

propidium and nsc 83265

propidium has been researched along with nsc 83265 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnetson, R; Doyle, B; Fleming, J; Kozielski, F; Leung, HY; Robson, CN; Singh, BL; Stockley, J; Wiltshire, C1

Other Studies

1 other study(ies) available for propidium and nsc 83265

ArticleYear
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cysteine; Docetaxel; Drug Screening Assays, Antitumor; Humans; Kinesins; Male; Propidium; Prostatic Neoplasms; Taxoids; Up-Regulation

2010